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Abstract
Background—It has become increasingly evident that disease flares in the human inflammatory
bowel diseases (IBD) are influenced by life stress. It is known that life stress can trigger
disturbances in intestinal barrier function and activate proinflammatory signaling pathways, which
are important contributors to intestinal inflammation and clinical disease; however, the exact
mechanisms of stress-induced IBD exacerbations remain to be elucidated. Here we present a
model of early life stress-induced exacerbation of colitis in IL-10-/- mice.
Methods—C57Bl/6 wild type and IL-10-/- mice were exposed to neonatal maternal separation
(NMS) stress on postnatal days 1-18 and reared under normal conditions until 10-12 weeks of age.
At this time, histopathology, colitis scores, intestinal barrier function, proinflammatory cytokine
expression and mast cell activity were evaluated.
Results—NMS increased the severity of colitis IL-10-/- mice indicated by greater colitis scores
and colonic proinflammatory cytokine concentrations. NMS and IL-10-/- increased colonic
permeability; however, NMS alone did not induce colitis. Increased mast cell activation and
colonic tryptase release were observed in IL-10-/- mice exposed to NMS, indicating mast cell
activation.
Conclusions—This study demonstrates that colitis in IL-10-/- mice can be exacerbated by NMS
stress. The precise mechanisms of enhanced colitis severity in NMS IL10-/- mice are unclear but
persistent defects in intestinal barrier function likely play a contributing role. NMS serves as a
novel model to investigate the mechanisms by which early life stress influences the development
and course of IBD in adulthood.
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The pathogenesis of IBD is multifactorial in nature, involving host genetic susceptibility,
dysregulated immune responses to the enteric microbiota, and environmental influences.
Life stress has been studied as a possible environmental trigger of IBD exacerbations. In one
analysis, 45% of UC patients reported a stressful life event within 12 months of diagnosis
compared to only 11% of matched hospital controls.1 Other studies have corroborated these
results, linking coping behavior, chronic stress, and relapse in IBD.2-6 Although
epidemiological analyses demonstrate a link between stress and IBD, the pathophysiological
mechanisms through which stress impacts the onset and clinical course of IBD are not
understood. Early life stressful events, including inadequate parental bonding and low
maternal care have become increasingly scrutinized as a possible risk factor for the
development of IBD later in life, but the biologic link between early life stress and
development of IBD remains poorly understood.7-9 Infancy, childhood, and adolescence are
critical periods in development that are characterized by increased vulnerability to stressors;
therefore, exposure of the developing brain and intestine to adverse environmental factors
may have long-lasting effects on the individual that may influence disease development and
activity in adulthood.7 Neonatal maternal separation (NMS) stress is a documented model of
early life stress which results in long-term alterations in behavior as a consequence.10, 11
The pathogenesis of IBD includes loss of intestinal epithelial barrier function and a
consequent increase in intestinal permeability. These factors allow excessive translocation of
luminal bacteria and antigens into subepithelial tissues, triggering a vicious cycle of chronic
intestinal inflammation and further intestinal barrier injury.12, 13 Several animal studies have
demonstrated that psychological stress negatively influences intestinal barrier function.14-16
In rodent and porcine animal models, early life stress resulted in permanent alterations in
central adaptive stress responses17 and chronic disturbances in intestinal barrier
function.18-20 Thus, intestinal barrier disturbances may serve as an important link between
stress and IBD flare-ups. The exact role of stress-induced barrier disruption causing the
exacerbation of IBD has not been investigated in animal models of naturally occurring
colitis.
The IL-10-/- mouse develops spontaneous colitis and therefore serves as a model commonly
utilized to study IBD. Conventionally reared IL-10-/- mice on the C57Bl/6 background
develop a mild, patchy colitis with incomplete disease penetrance;21 therefore, this
represents an ideal model to study the role of stress on the initiation and exacerbation of
colitis. The objective of this study was to investigate whether early life stress (NMS)
influences the development of colitis in IL-10-/- mice. We hypothesized that NMS would




Wild type and IL-10-/- mice on a C57Bl/6 background were obtained from the Jackson
Laboratories, Bar Harbor, ME, and were maintained in a specific pathogen free environment
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at the University of North Carolina, Chapel Hill. Litters were randomly assigned to one of
two groups: neonatal maternal separation stress (NMS) or control (normally reared). All
animals were housed in accordance with guidelines from the American Association for
Laboratory Animal Care and Research Protocols and experiments were approved by the
Institutional Animal Care and Use Committee of the University of North Carolina.
Neonatal Maternal Separation
NMS was performed as previously described by Chung.22 Briefly, pups in the NMS group
were removed from dams and placed in isolated warmed cages for 180 minutes daily for
postnatal days 1-18 (Figure 1). Following isolation, pups were returned to the cage
containing their dam and littermates and were left undisturbed other than routine bedding
changes.
Sample collection
Mice were sacrificed at 10 - 12 weeks of age and colonic samples were immediately
collected and divided for Ussing chamber experiments, histopathology, and colonic explant
cultures.
Histology
Colonic tissue sections were fixed in 10% buffered formalin, embedded in paraffin, and 4-
μm-thick sections were stained with hematoxylin and eosin using standard techniques.
Spontaneous colitis scoring was adapted from the criteria reported by Berg et al, as
previously described.21 All histological scores were determined by a single pathologist (LB)
who was blinded to the experimental protocols. Mucosal hypertrophy score was assigned as
follows: a clinical light microscope (Olympus BX45) equipped with a high resolution digital
camera (Olympus DP2-BSW version 2.2) was used to measure the colonic epithelial
thickness in microns. Well oriented crypts from 5 separate colon sections per mouse (n=5-6
mice/experimental group) and 6 randomly selected mucosal areas within each section were
measured from the basement membrane of the crypt base to the mucosal section using the
arbitrary line tool and the 20× objective. The average mucosal thickness of each of the 5
colon sections was expressed as a percentage of wild type colon epithelial thickness. The
percentages were then re-coded into a mucosal hypertrophy score (0 to 4) as follows: 0 =
90-125%; 1 = 125-150%; 2= 151-175%; 3= 176-200% and 4= >200 and summed for final
mucosal hypertrophy score. Inflammation was characterized for cell types as follows:
Additional sections were stained following standard immunohistochemical procedures for
CD3 as previously described23 and areas of inflammatory infiltrate, when available, were
targeted for examination in each of the 5 colon sections. At high magnification (40×
objective), 100 cell count differentials were performed with CD3 positive lymphocytes
counted as T. Macrophages, neutrophils and eosinophils were identified based on
morphology. Cell types were represented as percentage of inflammatory cells present.
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Intestinal tissue explant cultures—Sections of the colon were collected and processed
for IL-12 p40 as previously described,24 using a cytokine specific ELISA immunoassay kit
according to manufacturer's instructions (BD Biosystems, Franklin Lakes, NJ).
Quantitative real-time PCR, using SYBR Green Master Mix (Applied Biosystems, Bedford,
MA), was performed on an HT-7900 (Applied Biosystems, Bedford, MA), as previously
published.25
The following primer sequences were used: β-actin: forward, 5′-
AGCCATGTACGTAGCCATCCAG-3′, reverse, 5′-TGGCGTGAGGGAGAGCATAG-3′;
Ifng: forward, 5′-CTTCCTCATGGCTGTTTCTG-3′, reverse, 5′-
ACGCTTATGTTGCTGATGG-3′; Il12b: forward, 5′-
CGCAAGAAAGAAAAGATGAAGGAG-3′, reverse, 5′-TTGCATTGGACTTCGGTAGATG-3′;
Il17a: forward, 5′-AACCGTTCCACGTCACCCTGGA-3′, reverse, 5′-
TGGTCCAGCTTTCCCTCCGCA-3′; tnf: forward, 5′-TGAGATCCATGCCGTTGG-3′,
reverse, 5′- ACCCTCACACTCAGATCATCTTCTC-3′; Il6: forward, 5′-
GAAATGATGGATGCTACCAAACTG-3′, reverse, 5′-
CTCTCTGAAGGACTCTGGCTTTG-3′; Il1b: forward, 5′-
CTCAATGGACAGAATATCAACCAAC-3′, reverse, 5′-GGCTGTGCCGTCTTTCATTAC-3′
Intestinal Barrier Function
Ussing chamber experiments—Segments of proximal colon were harvested and
immediately placed in oxygenated (95% O2-5% CO2) Ringer solution. Tissues were then
mounted in 0.3 cm2 aperture Ussing chambers (Physiologic Instruments, Inc, San Diego,
CA) as described previously.26 After a 15-minute equilibration period on chambers, short
circuit current (Isc), an index of electrogenic ion transport, was monitored by a multichannel
voltage–current clamp (model VCC MC6, Physiologic Instruments, San Diego, CA) at 1
minute intervals over a 60-minute period and expressed as microamperes (μA) per square
centimeter. Mucosal-to-serosal flux of (FITC)-dextran (4 kDa; Sigma-Aldrich, St. Louis,
MO) (FD4) were performed as an index of paracellular permeability. After a 15 min
equilibration, FD4 (0.25 mM) was added to the mucosal side of Ussing chamber-mounted
tissues. The FD4 was allowed to equilibrate for 15 min, after which 100 μL samples (in
triplicate) were collected from the serosal side of tissues at 15 minute intervals and
transferred into a 96 well assay plate. The presence of FD4 was assayed by measurement of
fluorescence intensity using an fMax Fluorescence Microplate Reader (Molecular Devices,
Sunnyvale, CA) and concentrations were determined from standard curves generated by
serial dilution of FD4. FD4 flux across colonic tissues was determined by dividing the final
concentration of FD4 in the serosal chamber in the by the initial FD4 concentration of the
mucosal chamber and was expressed as % FD4 permeability.
Mast cell counts and assessment of mast cell product tryptase
Formalin-fixed, paraffin-embedded tissue (n=4 mice/experimental treatment) was mounted
on slides and stained with the mast cell granule stain toluidine blue. Lamina propria mast
cell counts were performed by an investigator blinded to experimental treatments. Mast cell
Lennon et al. Page 4






















counts were derived by averaging the number of mast cells observed in 10 high power fields
per tissue slide and were expressed as number of mast cells per high power field. The animal
served as the experimental unit for statistical analysis.
Gel electrophoresis and Western blotting
Supernatants from colonic explants were stored at −70°C before SDS-PAGE analysis.
Aliquots were thawed at 4°C, and protein analysis was performed (Pierce BCA protein assay
kit, Thermo Scientific, Rockford, IL). Aliquots (amounts equalized by protein
concentration) were mixed with an equal volume of 2× SDS-PAGE sample buffer and
boiled for 10 minutes. Western immunoblots for tryptase were performed using a mouse
mast cell tryptase primary antibody (Chemicon International, Temecula, CA) as previously
described.27 Quantitative results were obtained by scanning the resulting images and
densitometric analysis using QuantityOne software (Bio-Rad Laboratories, Hercules, CA).
Statistics
Data were reported as mean ± SE based on experimental number (n). Data were analyzed
using a standard 2-way ANOVA (SigmaStat, Jandel Scientific, San Rafael, CA) with stress
and genotype as the main effects. A post-hoc Tukey's test was used to determine differences
between experimental groups. Histology scores were compared using a Mann-Whitney U
test. p<0.05 was considered significant and p values ≥ 0.05 and ≤0.1 were reported as trends.
Cytokine data were analyzed with a Mann-Whitney U test using GraphPad Prism (Graphpad
software, San Diego, CA).
Results
Neonatal maternal separation exacerbates histologic colitis in IL-10 deficient mice
In IL-10-/- mice, NMS resulted in more severe colitis, characterized by marked colonic
epithelial hyperplasia as well as increased frequency and severity of inflammatory
aggregates within the lamina propria and submucosa compared to controls (Figure 2). The
inflammatory infiltrate consisted primarily of lymphocytes, with macrophages and
neutrophils representing less than 3% and 1% of the inflammatory cell infiltrate,
respectively (Table 1). Mice subjected to NMS had higher histological scores and decreased
colon length compared to controls (Figure 3). Crypt abscesses were not a prominent feature
of the colitis in these mice. Mice exposed to NMS displayed a trend towards higher
percentage of T-lymphocyte infiltration (p=0.05) than control mice. Mucosal hypertrophy
was evident in control and NMS mice, but was similar between the two groups. There was
no evidence of histological inflammation in the NMS group in wild type mice.
Neonatal maternal separation causes increased colonic proinflammatory cytokine
production in IL-10 deficient mice
NMS resulted in markedly elevated colonic IL-12 p40 levels in colonic explant cultures
compared to controls, as assessed by ELISA (Figure 4A). This elevation was also present at
the level of mRNA (Figure 4B). Colonic Ifng mRNA was also significantly elevated in
IL10-/- mice subjected to NMS compared to control mice (Figure 4C). Colonic levels of
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IL-1β, IL-6, IL-17, and TNFα were not significantly different between the two groups,
although these cytokines trended higher in the NMS group (Figure 4, D-G).
IL-10 deficiency and neonatal maternal separation stress compromise intestinal barrier
function
IL-10 deficiency and NMS had deleterious influences on colonic epithelial barrier function
in the present study. In colonic mucosa from control (no NMS), IL-10-/- mice exhibited
elevated colonic permeability (p<0.05; Figure 5) compared with wild type mice. NMS
induced elevations in colonic permeability to FD4 in both wild type and IL-10-/- mice.
IL-10-/- NMS mice exhibited the highest colonic permeability of all the experimental
groups.
Transepithelial short circuit current (Isc)
IL-10-/- mice displayed a trend for lower baseline colonic Isc compared with wild type
controls (p<0.01). Wild type mice subjected to NMS exhibited elevated Isc (p<0.05) values
compared with respective, normally-reared controls (Figure 6). Colonic mucosa from
IL-10-/- mice previously subjected to NMS exhibited a trend towards elevated Isc values
compared to normally reared IL-10-/- controls (p=0.058).
Mast cell activity
Mast cells have been previously demonstrated to mediate intestinal barrier dysfunction and
contribute to chemical-induced colitis;27-30 therefore, we evaluated the effects of NMS on
colonic mast cell activity in IL-10-/- mice. Colonic lamina propria mast cell counts, as
assessed by toluidine blue staining, displayed a trend towards a decrease in mice exposed to
NMS (p=0.10), indicative of increased mast cell activation and granule release. Consistent
with these results, tryptase concentrations in colonic explant supernatants were elevated
(p<0.05) in IL-10-/- mice exposed to NMS compared with normally reared mice.
Discussion
The results of this study demonstrate that NMS stress in IL-10-/- mice triggered the
development of severe colitis which was sustained later in life. NMS exacerbated colitis in
IL-10-/- mice, which was associated with marked defects in colonic epithelial function,
elevated proinflammatory cytokines, and evidence for enhanced mast cell activation.
Overall, these findings indicate that NMS in the IL-10-/- mouse represents a novel model for
studying the effect of stress on the pathogenesis of IBD.
In this study, normal reared IL-10-/- mice exhibited elevations in colonic permeability
compared with wild type controls demonstrating that IL-10 deficiency plays a role in
baseline regulation of intestinal barrier function. These findings are supported by Madsen et
al (1999) who showed that Sv/Ev 129, IL-10-/- mice exhibited a higher baseline intestinal
permeability compared with controls and this preceded colitis development. 31 A subsequent
study by Arrieta et al (2009) showed that administration of the zonulin antagonist
(AT-1001) significantly reduced small intestinal permeability and colitis indicating that
intestinal barrier dysfunction is a primary defect associated with colitis in IL-10-/- mice.32 In
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this study, we showed that NMS induced long-term increases in colonic permeability in wild
type and IL-10-/- mice; however, colitis was observed only in IL-10-/- mice subjected to
NMS. These findings support the “two-hit hypothesis” implicated in inflammatory bowel
disease, in which a single factor, such as genetic predisposition, barrier dysfunction, or
dysbiosis, is not sufficient to induce significant IBD.33
The precise mechanisms by which NMS resulted in long-lasting exacerbations in colitis in
IL-10-/- mice are unclear. In addition to causing increased intestinal permeability and more
severe colitis in IL-10-/- mice, NMS also caused an increase in intestinal permeability
without inducing colitis in wild type mice. Therefore, it is likely that the enhanced colonic
permeability observed in NMS-exposed mice results in increased luminal antigen and
adjuvant translocation across the intestinal epithelium, thus aggravating colitis in IL-10-/-
mice. Intestinal barrier dysfunction is a critical event that precedes inflammation in IBD
patients and animal models.32 In patients with Crohn's disease, increased intestinal
permeability is present and precedes inflammation and can predict relapse.34, 35 The
presence of intestinal barrier dysfunction in relatives of Crohn's disease patients suggests
that increased permeability may be a single early defect that may precede the development
of overt disease or may be a contributing factor to disease.36-39 In the current model,
increased intestinal permeability could be a cause or effect of the increase in colitis scores in
IL-10-/- mice. Further studies are necessary to determine if the increased colitis is preceded
by an increase in intestinal permeability.
Alternatively, enhanced colitis in stressed IL-10-/- mice could be due to the direct influence
of stress mediators on intestinal immune system. For example, peripheral stress mediators,
such as corticotrophin releasing factor (CRF) have been implicated as contributing to
intestinal inflammation independent of intestinal barrier dysfunction.40 For example, CRF
receptors are expressed on a variety of cell types in the intestine, including mast cells and
macrophages.41-43 CRF signaling on these cells may contribute to IBD either by triggering
intestinal barrier dysfunction or by initiating direct release of pro-inflammatory mediators
that in turn result in barrier dysfunction.41, 44-46 Although there were only modest effects of
NMS on measures of mast cell activation as evidenced by (1) a trend for decreased toluidine
blue-stained mast cells, an indicator or intracellular loss (exocytosis) of mast cell granule47
and (2) elevated colonic tryptase release, these data are in line with a well-established of the
mast cell in mediating intestinal barrier dysfunction30 and colitis.48-50 Mast cell tryptase has
been shown to induce multiple effects that can contribute to colitis including breakdown of
intestinal epithelial barrier function via tight junction protein disruption and neutrophil
recruitment. 50, 51 Given that we only assessed mast cell activation, the functional role of the
mast cell in this model remains to be fully understood.
In the present study, IL-10 deficiency and NMS induced alterations in Isc, an index of net
electrogenic ion transport. Baseline Isc was elevated by NMS in wild type mice and
displayed a trend towards increase in IL-10-/- mice, which is consistent with previous studies
utilizing NMS in rats.30, 52 Previous studies demonstrated that elevated Isc induced by NMS
was not observed in mast cell deficient rats suggesting that NMS induced mast cell
activation was responsible for the chronically elevated Isc.30 Although others have
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demonstrated altered Isc in several models of colitis, the direct role of altered Isc remains
unclear.53
In summary, stress is a major factor triggering the onset of IBD but the exact mechanisms
remain unclear. Here we present a novel animal model to investigate the mechanisms by
which early life stress influences development of IBD in adulthood. Future research into the
mechanisms through which stress influences IBD will provide insight into the mechanism of
stress-induced IBD onset or IBD flares and potentially reveal therapeutic targets that control
IBD development and relapse; therefore, this novel NMS/ IL-10-/- model may serve as a
useful model to study the influence of early life stress on the development of IBD in human
patients.
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Colon, H&E staining: Top row: 2× magnification; Bottom row: 60× magnification. NMS
IL-10-/- mice display marked epithelial hyperplasia compared to control. Increased
frequency and severity of inflammatory aggregates within the lamina propria and submucosa
of the NMS mouse (B and D) compared to the control mouse (A and C).
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Neonatal maternal separation stress exacerbates colitis. IL-10-/- mice (n=3-10/group) were
either exposed (NMS group) or not exposed (control group) to neonatal maternal separation.
(A) Colitis was more severe in NMS group as assessed by histologic colitis scores (p=0.01)
(B) Colon length was significantly decreased in IL-10-/- mice exposed to NMS (p<0.04)
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Colonic cytokine levels are increased in IL-10-/- mice subjected to NMS (n=5-10/group).
IL-12p40 (A; p<0.003), IL-12b mRNA (B; p<0.001), and IFNγ (C; p<0.05). IL-1β, IL-6,
IL-17, and TNFα were not significantly different from control mice (D-G).
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Neonatal maternal separation and IL-10 deficiency cause long-term alterations in colonic
barrier function. NMS caused significant increases in mucosal-to-serosal FITC-dextran flux
in wild type and IL-10-/- mice (b,c: p<0.05). Effects of NMS and IL-10 deficiency were
additive in causing increased permeability (c) (n=8/group).
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